EFM
DTIL icon

E Fund Management’s Precision BioSciences DTIL Stock Holding History

E Fund Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$122K Buy
+392
New +$137K 0.01% 234

Other funds holding DTIL

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

E Fund Management's DTIL Position: Q1 2021 in Review

E Fund Management opened a new position in Precision BioSciences (DTIL) in Q1 2021: 392 shares worth $122K. The stake represents 0.01% of the portfolio and ranks #234 among its holdings.

128 funds tracked by Wall St. Rank hold DTIL as of Q1 2021.

  • E Fund Management held 392 shares of Precision BioSciences worth $122K as of Q1 2021.
  • Precision BioSciences was a new E Fund Management position in Q1 2021.
  • Precision BioSciences made up 0.01% of E Fund Management's portfolio in Q1 2021, its #234 holding.
  • 128 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2021.

Based on E Fund Management's 13F filing for Q1 2021, filed 12 May 2021.